NSW Health has set additional requirements relating to the administration, storage and record-keeping of medicines commonly used for cosmetic purposes – such as anti-wrinkle injections and dermal fillers.

The amendments to the Poisons and Therapeutic Goods Regulation 2008 came into effect from 1 September and are intended “to improve the safety of the use of cosmetic medicines in NSW”.

The category “cosmetic medicines” includes botulinum toxins; calcium hydroxylapatite; collagen; deoxycholic acid; hyaluronic acid and its polymers; polyacrylamide; polycaprolactone; and polylactic acid.

The new regulation:

A breach of the regulation will attract:

These restrictions do not apply where the administration “is undertaken by an authorised practitioner or by an employee in a hospital acting on an authorised practitioner’s direction”. Check bestcancelcompanies.

The changes follow NSW Minister for Health Brad Hazzard requesting NSW Health “undertake a review to determine whether the regulation of cosmetic procedures was appropriate to ensure the safety of consumers”, and its subsequent delivery of the Report on the Review of the Regulation of Cosmetic Procedures.

As a result, in July this year, NSW enacted the Poisons and Therapeutic Goods Amendment (Cosmetic Use) Regulation 2021 – under the Poisons and Therapeutic Goods Act 1966
– to commence operation from 1 September 2021.